Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 13, Issue 2, 2000, Pages 75-79

  Shimizu, Hiroyuki ^a,d   Ohtani, K I ^a   Tsuchiya, T ^a   Sato, N ^b   Tanaka, Y ^a   Takahashi, H ^a   Uehara, Y ^a   Inukai, T ^c   Mori, M ^a  

^a GUNMA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE   (Japan)

Author keywords

Aldose reductase; mRNA; Neuropathy; Retinopathy; Type 2 diabetes mellitus

Indexed keywords

ALDEHYDE REDUCTASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; MESSENGER RNA;

AGED; ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE PREDISPOSITION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ALDEHYDE REDUCTASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MIDDLE AGED; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

UNIDENTIFIED AGENTS;

EID: 0034034490     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nathan D.M.: Relationship between metabolic control and long-term complications of diabetes. In: Kahn C.R., Weir G.C. (Eds), Joslin's Diabetes Mellitus. Lea & Febiger, Malvern, 1994, pp. 620-630.
2. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS). Lancet 352: 837-853, 1998.
4. King G.L., Banskota N.K.: Mechanism of diabetic microvascular complication. In: Kahn C.R., Weir G.C. (Eds), Joslin's Diabetes Mellitus. Lea & Febiger, Malvern, 1994, pp. 631-647.
5. Greene D.A.: Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism 32 (Suppl 1): 118-123, 1983.
6. Low P.A., Lagerlund T.D., McManis P.G.: Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31: 356-438, 1989.
7. Gabbay K.H.: The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 288: 831-836, 1973.
8. Greene D.A., Lattimer S.A., Sima A.A.F.: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316: 599-606, 1987.
9. Dent M.T., Tebbs S.E., Gonzalez A.M., Ward J.D., Wilson R.M.: Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabet. Med. 8: 439-442, 1991.
10. Hamada Y., Kitoh R., Raskin P.: Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus. Diabet. Med. 10: 33-38, 1993.
11. Nishimura C., Saito T., Ito T., Omori Y., Tanimoto T.: High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37: 328-330, 1994.
12. Bohren K.M., Bullock B., Wermuth B., Gabbay K.M.: The aldo-keto reductase superfamily: cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J. Biol. Chem. 264: 9547-9551, 1989.
13. Graham. A., Brown L., Hedge P.J., Gammack A.J., Markham A.F.: Structure of the human aldose reductase gene. J. Biol. Chem. 266: 6872-6877, 1991.
14. Shimizu H., Ohtani K., Sato N., Mori M.: Subjective symptom in diabetic neuropathy: a correlation with objective findings. Gendai Iryou 27 (Suppl. IV): 3383-3389, 1995.
15. Sato N., Wang X., Greer M.A.: Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. Am. J. Med. Sci. 289: 309-312, 1990.
16. Henry D.N., Del Monte M., Greene D.A., Killen P.D.: Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J. Clin. Invest. 92: 617-623, 1993.
17. Yamaoka T., Nishimura C., Yamashita K., Itakura M., Yamada T., Fujimoto J., Kokai Y.: Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38: 255-261, 1995.
18. Ratliff D.M., Vander Jagt D.L, Eaton R.P., Vander Jagt D.L.: Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II-a clinical research center study. J. Clin. Endocr. Metab. 81: 488-492, 1996.
19. Smardo F.L. Jr., Burg M.B., Garcia-Perez A.: Kidney aldose reductase gene transcription is osmotically regulated. Am. J. Physiol. 262: C776-C782, 1992.
20. Bekhor I., Shi S., Unakar N.J.: Management of aldose reductase mRNA abundance in rat lens undergoing reversal of galactose induced cataracts. A model for gene response to changes in the environment. Mol. Cell. Biochem. 95: 55-60, 1990.
21. Ohtake M., Tawata M., Hosaka Y., Onaya T.: Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells. Diabetologia 35: 730-734, 1992.
22. Ghahary A., Chakrabarti S., Sima A.A., Murphy L.J.: Effect of insulin and Statil on aldose reductase expression in diabetic rats. Diabetes 40: 1391-1396, 1991.
23. Kicic E., Palmer T.N.: Is sorbitol dehydrogenase gene expression affected by streptozotocin-diabetes in the rat. Biochim. Biophys. Acta 1226: 213-218, 1994.
24. 2 production are coordinately regulated in cultured mesangial cells. Metabolism 42: 269-276, 1993.
25. Pedal A., Ratanachaiyavong S., Millward A., Demaine A.G.: Polymorphism of the aldose reductase locus (ALR2) and susceptibility to diabetes microvascular complications. Adv. Exp. Med. Biol. 328: 325-332, 1993.
26. Ko B.C.B., Lam K.S.L., Wat N.M.S., Chung S.S.M.: An (A-C)n dinucleotide repeat polymorphic marker at the 5′-end of the aldose reductase gene is associated with early onset diabetic retinopathy in NIDDM. Diabetes 44: 727-732, 1995.
27. Shah V.O., Scavini M., Nikolic J., Sun Y., Vai S., Griffith J.K., Dorin R.I., Stidley C., Yacoub M., Vander-Jagt D.L., Eaton R.P., Zager P.G.: Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic neuropathy. J. Clin. Endocrinol. Metab. 83: 2886-2891, 1998.
28. Heesom A.E., Millward A., Demaine A.G.: Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J. Neurol. Neurosurg. Psychiatry. 64: 213-216, 1998.
29. Wang K., Bohren K.M., Gabbay K.H.: Characterization of the human aldose reductase gene promoter. J. Biol. Chem. 268: 16052-16058, 1993.
30. Williamson J.R., Rowold E., Chang K., Marbel J., Tomlinson N., Sherinan W.R., Ackermann K.E., Berger R.A., Kilo C.: Sex steroid dependency of diabetes: induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes 35: 20-27, 1986.
31. Klein B.E.K., Moss S.E., Klein R.: Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13: 34-40, 1990.
32. Bell D.S.H.: Lack of long-term diabetic complications in spite of poor glycemic control in twins with pure gonadal dysgenesis. Diabetes Care 18: 1286-1287, 1995.